Institutionelt og fondsejerskab - Købere
Større indehavere, der har åbnet nye stillinger i Ascletis Pharma Inc., omfatter AVEE - Avantis Emerging Markets Small Cap Equity ETF .
Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.
Opgrader for at låse op for premium-data.
Fil dato | Kilde | Investor | Type | Gennemsnitlig pris (Øst) |
Aktier | Δ Aktier (%) |
Rapporteret Værdi ($1000) |
Δ Værdi (%) |
Port Alloc (%) |
|
---|---|---|---|---|---|---|---|---|---|---|
2025-06-26 | NP | DFCEX - Emerging Markets Core Equity Portfolio - Institutional Class This fund is a listed as child fund of Dimensional Fund Advisors Lp and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 929.000 | 16,27 | 757 | 81,29 | ||||
2025-07-28 | NP | AVEM - Avantis Emerging Markets Equity ETF This fund is a listed as child fund of American Century Companies Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 1.372.000 | 582,59 | 1.337 | 686,47 | ||||
2025-07-28 | NP | AVSE - Avantis Responsible Emerging Markets Equity ETF | 43.000 | 10,26 | 42 | 24,24 | ||||
2025-07-28 | NP | AVEE - Avantis Emerging Markets Small Cap Equity ETF | 21.000 | 20 |